CVE-2021-25921: Cross-Site-Scripting in openemr
In OpenEMR, versions 2.7.3-rc1 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly in the `Allergies` section. An attacker could lure an admin to enter a malicious payload and by that initiate the exploit.
AI Analysis
Technical Summary
CVE-2021-25921 is a stored Cross-Site Scripting (XSS) vulnerability affecting OpenEMR versions from 2.7.3-rc1 through 6.0.0. OpenEMR is an open-source electronic medical record and practice management software widely used in healthcare settings. The vulnerability arises from improper validation and sanitization of user input in the 'Allergies' section of the application. Specifically, an attacker can craft a malicious payload that, when entered by an authenticated user with elevated privileges (such as an administrator), is stored persistently in the system. This payload is then executed in the context of any user viewing the affected data, leading to the execution of arbitrary JavaScript code within the victim's browser. The attack vector requires the attacker to lure an authorized user to input the malicious code, implying that some degree of social engineering or insider threat is necessary. The CVSS v3.1 base score is 5.4 (medium severity), with the vector indicating network attack vector (AV:N), low attack complexity (AC:L), privileges required (PR:L), user interaction required (UI:R), scope changed (S:C), and low impact on confidentiality and integrity, with no impact on availability. The vulnerability is classified under CWE-79 (Improper Neutralization of Input During Web Page Generation). No known public exploits have been reported in the wild, and no official patches are linked in the provided data, though it is likely that later OpenEMR versions or community updates address this issue. The vulnerability's exploitation can lead to session hijacking, credential theft, or unauthorized actions performed in the context of the victim user, potentially exposing sensitive patient data or allowing manipulation of medical records.
Potential Impact
For European organizations, particularly healthcare providers using OpenEMR, this vulnerability poses a significant risk to the confidentiality and integrity of sensitive patient information. Successful exploitation could enable attackers to execute malicious scripts that steal session cookies, enabling unauthorized access to patient records or administrative functions. This could lead to data breaches violating GDPR regulations, resulting in legal penalties and reputational damage. Additionally, manipulation of medical data could impact patient care quality and safety. The requirement for an authenticated user with privileges to input the malicious payload limits the attack surface but does not eliminate risk, especially in environments where insider threats or phishing attacks are plausible. The scope change in the CVSS vector indicates that the vulnerability can affect resources beyond the initially vulnerable component, potentially impacting multiple users or systems within the healthcare network. Given the critical nature of healthcare data and the increasing targeting of healthcare infrastructure by cybercriminals in Europe, the impact is non-trivial despite the medium CVSS score.
Mitigation Recommendations
1. Immediate mitigation involves restricting access to the 'Allergies' input fields to only trusted and trained personnel, minimizing the risk of malicious input. 2. Implement strict input validation and output encoding on all user-supplied data within the OpenEMR application, especially in the Allergies section, to neutralize any embedded scripts. 3. Upgrade OpenEMR installations to the latest version where this vulnerability is patched; if no official patch is available, apply community-recommended fixes or custom input sanitization. 4. Employ Content Security Policy (CSP) headers to limit the execution of unauthorized scripts in the browser context. 5. Conduct regular security awareness training for administrators and users with elevated privileges to recognize and avoid social engineering attempts that could lead to malicious input. 6. Monitor logs for unusual input patterns or script injections in the Allergies section and implement anomaly detection to identify potential exploitation attempts. 7. Use web application firewalls (WAFs) configured to detect and block XSS payloads targeting OpenEMR. 8. Segregate OpenEMR systems within the network to limit lateral movement if exploitation occurs. These measures, combined, reduce the likelihood and impact of exploitation beyond generic patching advice.
Affected Countries
Germany, France, United Kingdom, Italy, Spain, Netherlands, Belgium, Sweden, Poland, Austria
CVE-2021-25921: Cross-Site-Scripting in openemr
Description
In OpenEMR, versions 2.7.3-rc1 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly in the `Allergies` section. An attacker could lure an admin to enter a malicious payload and by that initiate the exploit.
AI-Powered Analysis
Technical Analysis
CVE-2021-25921 is a stored Cross-Site Scripting (XSS) vulnerability affecting OpenEMR versions from 2.7.3-rc1 through 6.0.0. OpenEMR is an open-source electronic medical record and practice management software widely used in healthcare settings. The vulnerability arises from improper validation and sanitization of user input in the 'Allergies' section of the application. Specifically, an attacker can craft a malicious payload that, when entered by an authenticated user with elevated privileges (such as an administrator), is stored persistently in the system. This payload is then executed in the context of any user viewing the affected data, leading to the execution of arbitrary JavaScript code within the victim's browser. The attack vector requires the attacker to lure an authorized user to input the malicious code, implying that some degree of social engineering or insider threat is necessary. The CVSS v3.1 base score is 5.4 (medium severity), with the vector indicating network attack vector (AV:N), low attack complexity (AC:L), privileges required (PR:L), user interaction required (UI:R), scope changed (S:C), and low impact on confidentiality and integrity, with no impact on availability. The vulnerability is classified under CWE-79 (Improper Neutralization of Input During Web Page Generation). No known public exploits have been reported in the wild, and no official patches are linked in the provided data, though it is likely that later OpenEMR versions or community updates address this issue. The vulnerability's exploitation can lead to session hijacking, credential theft, or unauthorized actions performed in the context of the victim user, potentially exposing sensitive patient data or allowing manipulation of medical records.
Potential Impact
For European organizations, particularly healthcare providers using OpenEMR, this vulnerability poses a significant risk to the confidentiality and integrity of sensitive patient information. Successful exploitation could enable attackers to execute malicious scripts that steal session cookies, enabling unauthorized access to patient records or administrative functions. This could lead to data breaches violating GDPR regulations, resulting in legal penalties and reputational damage. Additionally, manipulation of medical data could impact patient care quality and safety. The requirement for an authenticated user with privileges to input the malicious payload limits the attack surface but does not eliminate risk, especially in environments where insider threats or phishing attacks are plausible. The scope change in the CVSS vector indicates that the vulnerability can affect resources beyond the initially vulnerable component, potentially impacting multiple users or systems within the healthcare network. Given the critical nature of healthcare data and the increasing targeting of healthcare infrastructure by cybercriminals in Europe, the impact is non-trivial despite the medium CVSS score.
Mitigation Recommendations
1. Immediate mitigation involves restricting access to the 'Allergies' input fields to only trusted and trained personnel, minimizing the risk of malicious input. 2. Implement strict input validation and output encoding on all user-supplied data within the OpenEMR application, especially in the Allergies section, to neutralize any embedded scripts. 3. Upgrade OpenEMR installations to the latest version where this vulnerability is patched; if no official patch is available, apply community-recommended fixes or custom input sanitization. 4. Employ Content Security Policy (CSP) headers to limit the execution of unauthorized scripts in the browser context. 5. Conduct regular security awareness training for administrators and users with elevated privileges to recognize and avoid social engineering attempts that could lead to malicious input. 6. Monitor logs for unusual input patterns or script injections in the Allergies section and implement anomaly detection to identify potential exploitation attempts. 7. Use web application firewalls (WAFs) configured to detect and block XSS payloads targeting OpenEMR. 8. Segregate OpenEMR systems within the network to limit lateral movement if exploitation occurs. These measures, combined, reduce the likelihood and impact of exploitation beyond generic patching advice.
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- Mend
- Date Reserved
- 2021-01-22T00:00:00.000Z
- Cisa Enriched
- true
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 682d983ac4522896dcbedab6
Added to database: 5/21/2025, 9:09:14 AM
Last enriched: 6/25/2025, 11:01:21 AM
Last updated: 8/1/2025, 1:40:12 PM
Views: 11
Related Threats
CVE-2025-57703: CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in Delta Electronics DIAEnergie
MediumCVE-2025-57702: CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in Delta Electronics DIAEnergie
MediumCVE-2025-57701: CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in Delta Electronics DIAEnergie
MediumCVE-2025-57700: CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in Delta Electronics DIAEnergie
HighCVE-2025-9109: Observable Response Discrepancy in Portabilis i-Diario
MediumActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.